Please Wait
Applying Filters...
menu
    • menu
    TAPI, a leading global supplier of APIs, provides over 350 products and customized CDMO solutions for every stage of development.

    Virtual Booth

    Contact Supplier

    Your reliable CDMO partner - agile, scalable, top-quality Small Molecule API & HPAPI solutions from concept to market

    Virtual Booth

    Contact Supplier

    pharmacompass-1-m-2025-11-24

    Virtual Booth

    An Enquiry

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Bachem Group is a public, innovation-driven company specializing in the development and manufacturing of peptides and oligonucleotides.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    An Enquiry

    Menu

    Sulfasalazine

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    INTERMEDIATES

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    PharmaCompass
    $ API Ref.Price (USD/KG) : 32Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Rising’s Generics Sulfasalazine Receives Approval in US
    Rising’s Generics Sulfasalazine Receives Approval in US

    04 Nov 2025

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=219046

    FDA
    04 Nov 2025
    Share Share
    The Association of Methotrexate, Sulfasalazine and Hydroxychloroquine Use
    The Association of Methotrexate, Sulfasalazine and Hydroxychloroquine Use

    09 Nov 2020

    // ACRABSTRACTS

    https://acrabstracts.org/abstract/the-association-of-methotrexate-sulfasalazine-and-hydroxychloroquine-use-with-incident-fractures-in-postmenopausal-women-with-rheumatoid-arthritis-findings-from-the-womens-health-initiative/

    ACRABSTRACTS
    09 Nov 2020
    Share Share
    Generic Version of Delzicol® Delayed-Release Capsules Launched in the US
    Generic Version of Delzicol® Delayed-Release Capsules Launched in the US

    10 May 2019

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20190510005380/en/Teva-Announces-Launch-Generic-Version-Delzicol%C2%AE-mesalamine

    BUSINESSWIRE
    10 May 2019
    Share Share
    DCGI directs state DCs to ask manufacturers of 7 drugs, identified ADRs drugs
    DCGI directs state DCs to ask manufacturers of 7 drugs, identified ADRs drugs

    12 Apr 2019

    // PHARMABIZ

    http://pharmabiz.com/ArticleDetails.aspx?aid=115187&sid=1

    PHARMABIZ
    12 Apr 2019
    Share Share
    Health Canada Issues Recall of Pharmascience`s PMS-Sulfasalazine 500 mg Tablet USP
    Health Canada Issues Recall of Pharmascience`s PMS-Sulfasalazine 500 mg Tablet USP

    10 Apr 2019

    // HEALTH CANADA

    https://healthycanadians.gc.ca/recall-alert-rappel-avis/hc-sc/2019/69612r-eng.php

    HEALTH CANADA
    10 Apr 2019
    Share Share
    GSK announces positive results from two phIII studies of sirukumab
    GSK announces positive results from two phIII studies of sirukumab

    18 Nov 2016

    // PHARMABIZ

    http://www.pharmabiz.com/NewsDetails.aspx?aid=98747&sid=2

    PHARMABIZ
    18 Nov 2016
    Share Share